These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27277347)

  • 1. Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients.
    Karim MR; Ahmed H; Paul RK; Chowdhury M; Alam MS; Saha A
    Mymensingh Med J; 2016 Apr; 25(2):198-204. PubMed ID: 27277347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease.
    El-Haggar SM; Mostafa TM
    Hepatol Int; 2015 Jul; 9(3):471-9. PubMed ID: 25956613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
    Corey KE; Rinella ME
    Dig Dis Sci; 2016 May; 61(5):1387-97. PubMed ID: 26942734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
    Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease.
    Yaghoubi M; Jafari S; Sajedi B; Gohari S; Akbarieh S; Heydari AH; Jameshoorani M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1385-1388. PubMed ID: 29023319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence.
    Tang JT; Mao YM
    J Dig Dis; 2017 Nov; 18(11):607-617. PubMed ID: 29106066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone increases serum magnesium levels in glucose-intolerant subjects. A randomized, controlled trial.
    Guerrero-Romero F; Rodríguez-Morán M
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):91-6. PubMed ID: 12746760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinedione therapy versus lifestyle recommendation in the treatment of post-liver transplant graft steatosis.
    Åberg F; Koljonen V; Nikkilä K; Boyd S; Arola J; Isoniemi H
    Ann Transplant; 2014 Aug; 19():389-96. PubMed ID: 25105443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis.
    Kawaguchi-Suzuki M; Bril F; Kalavalapalli S; Cusi K; Frye RF
    Aliment Pharmacol Ther; 2017 Jul; 46(1):56-61. PubMed ID: 28470881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
    Gad MZ; Ehssan NA; Ghiet MH; Wahman LF
    Pak J Pharm Sci; 2010 Jul; 23(3):305-12. PubMed ID: 20566445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism.
    Yan H; Wu W; Chang X; Xia M; Ma S; Wang L; Gao J
    Biol Sex Differ; 2021 Jan; 12(1):1. PubMed ID: 33397443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
    Surapaneni KM; Priya VV; Mallika J
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies.
    Zeng T; Zhang CL; Zhao XL; Xie KQ
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):646-53. PubMed ID: 24743504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pioglitazone on the liver of streptozotocin-induced diabetic albino Wistar rats.
    El Gawly HW; Tawfik MK; Rashwan ME; Baruzaig AS
    Eur Rev Med Pharmacol Sci; 2009; 13(6):443-51. PubMed ID: 20085125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 20. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
    Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
    N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.